Correction of patient-specific induced pluripotent stem cells (iPSC) upon gene delivery through retroviral vectors offers new treatment perspectives for monogenetic diseases. Gene-modified iPSC clones ...
* Vector Group Ltd - expects to incur an after-tax charge of about $11 million in Q4 of 2016 related to settlement agreement-sec filing Sign up here. * Says upon dismissal of settled cases, company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback